CA1047924A - Powdered emulsion product and method of production - Google Patents

Powdered emulsion product and method of production

Info

Publication number
CA1047924A
CA1047924A CA212,545A CA212545A CA1047924A CA 1047924 A CA1047924 A CA 1047924A CA 212545 A CA212545 A CA 212545A CA 1047924 A CA1047924 A CA 1047924A
Authority
CA
Canada
Prior art keywords
oil
emulsion
water
drug
aqueous solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA212,545A
Other languages
English (en)
French (fr)
Other versions
CA212545S (en
Inventor
Hitoshi Sezaki
Shozo Muranishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP48121929A external-priority patent/JPS582927B2/ja
Priority claimed from JP48121930A external-priority patent/JPS582928B2/ja
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of CA1047924A publication Critical patent/CA1047924A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
CA212,545A 1973-10-30 1974-10-29 Powdered emulsion product and method of production Expired CA1047924A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP48121929A JPS582927B2 (ja) 1973-10-30 1973-10-30 フンマツセイヒンノ セイゾウホウ
JP48121930A JPS582928B2 (ja) 1973-10-30 1973-10-30 粉末製品の製造法

Publications (1)

Publication Number Publication Date
CA1047924A true CA1047924A (en) 1979-02-06

Family

ID=26459174

Family Applications (1)

Application Number Title Priority Date Filing Date
CA212,545A Expired CA1047924A (en) 1973-10-30 1974-10-29 Powdered emulsion product and method of production

Country Status (4)

Country Link
CA (1) CA1047924A (enExample)
DE (1) DE2451568A1 (enExample)
FR (1) FR2257267B1 (enExample)
GB (1) GB1488522A (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4655941A (en) * 1984-02-13 1987-04-07 Tomita Pharmaceutical Corp., Ltd. Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
IL78930A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Lyophilized emulsion compositions for parenteral administration
GB8607717D0 (en) * 1986-03-27 1986-04-30 Unilever Plc Hydratable powders
JP5096138B2 (ja) * 2005-03-31 2012-12-12 サントリーホールディングス株式会社 リグナン類化合物含有水中油滴型エマルション及びそれを含有する組成物
NL2002046C (en) * 2008-10-01 2010-04-02 Friesland Brands Bv Double emulsion and method to produce such.
CN101856018B (zh) * 2010-06-18 2011-11-23 冀京民 醚菊酯可乳化粉剂及制造方法

Also Published As

Publication number Publication date
FR2257267A1 (enExample) 1975-08-08
GB1488522A (en) 1977-10-12
DE2451568A1 (de) 1975-05-07
FR2257267B1 (enExample) 1979-07-27

Similar Documents

Publication Publication Date Title
DE69727244T2 (de) Hydrophile Mikroteilchen und Verfahren zu deren Herstellung
US4011661A (en) Powdered emulsion product and method of production
DE69023682T2 (de) Gefriergetrocknete Polymerdispersionen und ihre Anwendung zur Darstellung von Arzneimittelzubereitungen mit protrahierter Wirkstoffabgabe.
GR3001710T3 (en) Pharmaceutical formulation and process for its preparation
KR910004091A (ko) 투약 디바이스와 그 제조 방법 및 사용방법
KR19980701770A (ko) 미셀 미소입자
CA1047924A (en) Powdered emulsion product and method of production
CA2091152A1 (en) Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
KR101116899B1 (ko) 안정한 농축형 및 희석형 수중유형 에멀젼
JPH04226911A (ja) 医薬の投与に適する安定乳濁液、その製造方法および医薬として使用されるべき乳濁液
NZ517024A (en) Veterinary formulation for administration of a water-insoluble drug to a target animal through a water distribution system
CN110464707A (zh) 一种熊果酸稳定的水包油型皮克林乳液及其制备方法
JP3386349B2 (ja) 水性懸濁医薬品組成物
EP3258920A1 (en) Solid pharmaceutical dosage form suitable for use as drinking water medication
CN104055738A (zh) 利用具有溶胶-凝胶转变特性的聚合物制备微球的方法以及由此制备的微球
JP4822092B2 (ja) Ｗ／ｏ／ｗ型複合エマルション
US20040115275A1 (en) Particle embedded with chemical substances and method of producing a particle
KR20190088026A (ko) 나노셀룰로오스를 함유한 나노에멀젼 유화 조성물 및 이의 제조 방법
JPS59139310A (ja) 乳化組成物
US6455072B1 (en) Stable aqueous dispersion of nutrients
US2940900A (en) Dry vitamine e composition
CN115518030B (zh) 一种二甲硅油乳膏剂的制备方法
EP0350913A1 (en) Ibudilast lipid microsphere and method of preparation thereof
EP1227780A2 (en) A stable aqueous dispersion of nutrients
KR100329336B1 (ko) 히아루론산을 이용한 단백질 약물의 서방성 미세 입자 제형